Designed Repeat Proteins: Novel Receptor Molecules for Life Science, Diagnostics and Therapy

Schrift Standard Fett
Login

Forschungsstelle

INNOSUISSE

Projektnummer

7505.1;6 DCPP-LS

Projekttitel

Designed Repeat Proteins: Novel Receptor Molecules for Life Science, Diagnostics and Therapy

Projekttitel Englisch

Designed Repeat Proteins: Novel Receptor Molecules for Life Science, Diagnostics and Therapy

Texte zu diesem Projekt

	Deutsch	Französisch	Italienisch	Englisch
Kurzbeschreibung	-	-	-
Abstract	-	-	-

Erfasste Texte

Kategorie	Text
Kurzbeschreibung (Englisch)	Designed Repeat Proteins: Novel Receptor Molecules for Life Science, Diagnostics and Therapy
Abstract (Englisch)	We developed a novel class of receptor proteins, Designed Repeat Proteins (DRPs), with an extraordinary potential to complement and substitute classical antibodies in biotechnological, diagnostic and therapeutic applications. DRPs possess affinities and specificities of antibodies, but surpass them in expression yield, stability and intracellular efficacy. The aim of this KTI-Discovery project is now to develop a range of commercial applications based on the DRP technology.

Kategorie

Text

Kurzbeschreibung
(Englisch)

Designed Repeat Proteins: Novel Receptor Molecules for Life Science, Diagnostics and Therapy

Abstract
(Englisch)

We developed a novel class of receptor proteins, Designed Repeat Proteins (DRPs), with an extraordinary potential to complement and substitute classical antibodies in biotechnological, diagnostic and therapeutic applications. DRPs possess affinities and specificities of antibodies, but surpass them in expression yield, stability and intracellular efficacy. The aim of this KTI-Discovery project is now to develop a range of commercial applications based on the DRP technology.